Improving Cognitive Functions with Frontal-vagal rTMS in Normal Aging and Cognitively Impaired adults

niversitätsmedizin Göttingen0 个研究点目标入组 80 人开始时间: 2024年2月6日最近更新: 2024年8月19日

适应症

试验速览

暂无简介。

•1. Severe Cardiovascular diseases such as Heart Failure (EF < 45%), any Arrythmias (such as Atrial Fibrillation, Sick sinus syndrome or Bradycardias), Heart Valves Insufficiency or Stenosis;
•2. History of Myocardial Infarction and/or Cardiac Arrest, CPR or Cardiovascular Surgery;
•3. Heart Pacemaker or Defibrillator, or other Heart Devices;
•4. Anticoagulation therapy related to cardiovascular disease;
•5. Metal implants in the head area (e.g. clips after surgery of an intracerebral aneurysm, implantation of an artificial cochlea);
•6. Evidence of a chronic disease or residuals (remnants) of a neurological disease (disease of the nervous system) in history; History of intracerebral ischemia (insufficient blood flow to the brain/stroke); Evidence of a history of epileptic seizures or stroke; multiple sclerosis;
•6. Presence of a serious internal or neurological disease (e.g. untreated tumors, cancer, Parkinson's disease, multiple sclerosis);
•7. Psychiatric diseases (schizophrenia, major depression);
•8. Head trauma with a history of loss of consciousness;
•9. Glaucoma, retinitis pigmentosa, macular degeneration in an advanced stadium;
•10. Alcohol or drug addiction;
•11. Operations within the last three months;
•12. Participation in another clinical trial within the last 6 weeks.

发起方

niversitätsmedizin Göttingen